The search for a potential prognostic role of p16 methylation in NSCLC survival is based on its frequent hypermethylation in NSCLC and also on its potential interference with most pathways implicated in tumorigenesis. This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.